Moustafa T. Gabr

CAR T cell therapy beyond cancer: current status, challenges and future prospects

Chimeric antigen receptor (CAR) T-cell therapy has revolutionized oncology, and its foundational logic-precise antigen recognition coupled with durable effector activity-extends naturally to chronic non-malignant diseases sustained by long-lived pathological cells. These include...